Incyte Reports 2017 Fourth-Quarter and Year-End Financial Results, Provides 2018 Financial Guidance and Updates on Key Clinical Programs
Go back to Incyte Reports 2017 Fourth-Quarter and Year-End Financial Results, Provides 2018 Financial Guidance and Updates on Key Clinical Programs| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 124.40 -2.35 (1.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $126.75 | 52 Week High | $118.49 | |||
| Open | $124.11 | 52 Week Low | $55.00 | |||
| Day High | $126.40 | P/E | N/A | |||
| Day Low | $122.22 | EPS | $-0.56 | |||
| Volume | 1,283,253 | |||||
